Didanosine

What is Didanosine?

Didanosine is a prescription nucleoside reverse transcriptase inhibitor (NRTI) used as part of combination therapy for HIV-1 infection. It helps reduce the amount of virus in the body, improving immune function and delaying disease progression. Available in delayed-release capsules and powder for oral solution, it requires a doctor's guidance due to potential side effects and dosing complexity.

Key features

• Antiretroviral Class — Nucleoside reverse transcriptase inhibitor (NRTI).
• Dosage Forms — Delayed-release capsules and powder for oral solution.
• Prescription Required — Must be used under medical supervision.
• Combination Therapy — Used with other antiretrovirals for HIV treatment.
• Storage Requirements — Refrigeration needed for reconstituted oral solution.
• Dosing Frequency — Typically once or twice daily, depending on formulation.
• Target Population — Adults and pediatric patients meeting clinical criteria.

Who is Didanosine for?

This medication is intended for individuals diagnosed with HIV-1 infection, particularly those who may have developed resistance to other NRTIs or require alternative regimens due to intolerance. It is not a cure but helps manage viral load and improve quality of life when used consistently. Patients must be monitored regularly for liver function, pancreatitis, and peripheral neuropathy risks.

How does Didanosine compare?

Compared to newer antiretrovirals, Didanosine has a higher risk profile, including mitochondrial toxicity and long-term metabolic effects. While effective, it's less commonly prescribed today due to safer alternatives like tenofovir or integrase inhibitors. However, it remains an option in specific treatment-experienced cases or resource-limited settings where drug access is restricted.